---
schema_version: "secwatch.filing_event.v1"
accession: "0001835268-25-000039"
form_type: "8-K"
ticker: "CNTB"
cik: "0001835268"
company_name: "Connect Biopharma Holdings Ltd"
filed_at: "2025-07-17T23:59:59+00:00"
generated_at: "2026-05-18T05:59:56.684391+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Connect Biopharma regains Nasdaq minimum bid price compliance; delisting risk removed

## Summary
- Received Nasdaq letter on July 17, 2025 confirming compliance with Minimum Bid Price Requirement.
- Regained compliance after ADSs closed at or above $1.00 for 10 consecutive business days through July 15, 2025.
- Non-compliance was first notified on March 24, 2025; cure period ran to September 22, 2025.
- Matter is now closed; no further action required to maintain listing.
- Removal of delisting risk supports continued trading on Nasdaq Global Market.

## SEC filing metadata
- accession: 0001835268-25-000039
- form_type: 8-K
- ticker: CNTB
- cik: 0001835268
- company_name: Connect Biopharma Holdings Ltd
- filed_at: 2025-07-17T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1835268/000183526825000039/0001835268-25-000039-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1835268/000183526825000039/cntb-20250716.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001835268-25-000039
- JSON: https://secwatch.observer/filing/0001835268-25-000039.json
- Plain text: https://secwatch.observer/filing/0001835268-25-000039.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.